Cefotaxime Sodium Powder for Solution Shortage: Current Status and Manufacturer Updates
Areazine synthesizes this FDA drug-shortage notice directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Cefotaxime Sodium Powder for Solution is currently in shortage due to increased demand, with Hikma Pharmaceuticals reporting total unavailability across all presentations.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, Cefotaxime Sodium.
What's in Shortage
Drug Name: Cefotaxime Sodium Powder, for Solution (Brand Name: CEFOTAXIME) Dosage Form: Powder, For Solution Therapeutic Category: Anti-Infective, Pediatric Current Status: Current Shortage
Which Manufacturers Are Affected
Hikma Pharmaceuticals USA, Inc.
- Status: Unavailable
- Notes: Shortage duration is unknown at this time.
- Affected Presentations:
- Cefotaxime Sodium, Powder, for Solution, 500 mg (NDC 0143-9930-10)
- Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 0143-9931-25)
- Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 0143-9933-25)
- Cefotaxime Sodium, Powder, for Solution, 10 g (NDC 0143-9935-01)
- Contact Information: 800-631-2174
Why There's a Shortage
The FDA reports that the shortage of Cefotaxime Sodium is due to a demand increase for the drug.
What Patients Should Do
If you or your child are prescribed this medication, please take the following steps:
- Consult Your Healthcare Provider: Discuss the shortage with your doctor to determine the best course of action for treatment.
- Talk to Your Pharmacist: Pharmacists may have information on local stock or potential alternatives.
- Contact the Manufacturer: You can reach Hikma Pharmaceuticals at 800-631-2174 for the most recent updates on availability.
Disclaimer: Patients should always consult their healthcare provider for medical advice and treatment options. Do not change or stop medication without professional guidance.
Source
Information provided by the FDA Drug Shortage Database.
- Initial Posting Date: 02/17/2015
- Last Updated: 03/12/2026
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Frequently Asked Questions
Common questions about this FDA drug-shortage notice.